Biogenic amines in the colon

[1] Aguilar M.J., Morales-Olivas F.J., Rubio E.: Pharmacological investigation into the effects of histamine and histamine analogues on guinea-pig and rat colon in vitro. Br. J. Pharmacol., 1986; 88: 501–506 AguilarM.J. Morales-OlivasF.J. RubioE. Pharmacological investigation into the effects of histamine and histamine analogues on guinea-pig and rat colon in vitro Br. J. Pharmacol. 1986 88 501 506 10.1111/j.1476-5381.1986.tb10229.x19169983742147 Search in Google Scholar

[2] Akyuz C., Yasar N.F., Uzun O., Peker K.D., Sunamak O., Duman M., Sehirli A.O., Yol S.: Effects of melatonin on colonic anastomosis healing following chemotherapy in rats. Singapore Med. J., 2018; 59: 545–549 AkyuzC. YasarN.F. UzunO. PekerK.D. SunamakO. DumanM. SehirliA.O. YolS. Effects of melatonin on colonic anastomosis healing following chemotherapy in rats Singapore Med. J. 2018 59 545 549 10.11622/smedj.2018035619919629552688 Search in Google Scholar

[3] Auteri M., Zizzo M.G., Amato A., Serio R.: Dopamine induces inhibitory effects on the circular muscle contractility of mouse distal colon via D1- and D2-like receptors. J. Physiol. Biochem., 2016; 73: 395–404 AuteriM. ZizzoM.G. AmatoA. SerioR. Dopamine induces inhibitory effects on the circular muscle contractility of mouse distal colon via D1- and D2-like receptors J. Physiol. Biochem. 2016 73 395 404 10.1007/s13105-017-0566-028600746 Search in Google Scholar

[4] Barbara G., Cremon C., De Giorgio R., Dothel G., Zecchi L., Bellacosa L., Carini G., Stanghellini V., Corinaldesi R.: Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr. Gastroenterol. Rep., 2011; 13: 308–315 BarbaraG. CremonC. De GiorgioR. DothelG. ZecchiL. BellacosaL. CariniG. StanghelliniV. CorinaldesiR. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome Curr. Gastroenterol. Rep. 2011 13 308 315 10.1007/s11894-011-0195-721537962 Search in Google Scholar

[5] Barger G., Dale H.H.: Chemical structure and sympathomimetic action of amines. J. Physiol., 1910; 41: 19–59 BargerG. DaleH.H. Chemical structure and sympathomimetic action of amines J. Physiol. 1910 41 19 59 10.1113/jphysiol.1910.sp001392151303216993040 Search in Google Scholar

[6] Bearcroft C.P., Perrett D., Farthing M.J.: Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: A pilot study. Gut, 1998; 42: 42–46 BearcroftC.P. PerrettD. FarthingM.J. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: A pilot study Gut 1998 42 42 46 10.1136/gut.42.1.4217269719505884 Search in Google Scholar

[7] Beaulieu J.M., Gainetdinov R.R.: The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev., 2011; 63: 182–217 BeaulieuJ.M. GainetdinovR.R. The physiology, signaling, and pharmacology of dopamine receptors Pharmacol. Rev. 2011 63 182 217 10.1124/pr.110.00264221303898 Search in Google Scholar

[8] Breunig E., Michel K., Zeller F., Seidl S., Weyhern C.W., Schemann M.: Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors. J. Physiol., 2007; 583: 731–742 BreunigE. MichelK. ZellerF. SeidlS. WeyhernC.W. SchemannM. Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors J. Physiol. 2007 583 731 742 10.1113/jphysiol.2007.139352227702517627982 Search in Google Scholar

[9] Bubenik G.A.: Thirty four years since the discovery of gastrointestinal melatonin. J. Physiol. Pharmacol., 2008; 59: 33–51 BubenikG.A. Thirty four years since the discovery of gastrointestinal melatonin J. Physiol. Pharmacol. 2008 59 33 51 Search in Google Scholar

[10] Bülbring E., Crema A.: Observations concerning the action of 5-hydroxytryptamine on the peristaltic reflex. Br. J. Pharmacol. Chemother., 1958; 13: 444–457 BülbringE. CremaA. Observations concerning the action of 5-hydroxytryptamine on the peristaltic reflex Br. J. Pharmacol. Chemother. 1958 13 444 457 10.1111/j.1476-5381.1958.tb00236.x148187213618550 Search in Google Scholar

[11] Bülbring E., Crema A.: The release of 5-hydroxytryptamine in relation to pressure exerted on the intestinal mucosa. J. Physiol., 1959; 146: 18–28 BülbringE. CremaA. The release of 5-hydroxytryptamine in relation to pressure exerted on the intestinal mucosa J. Physiol. 1959 146 18 28 10.1113/jphysiol.1959.sp006175135688713655213 Search in Google Scholar

[12] Bülbring E., Lin R.C.: The effect of intraluminal application of 5-hydroxytryptamine and 5-hydroxytryptophan on peristalsis; the local production of 5-HT and its release in relation to intraluminal pressure and propulsive activity. J. Physiol., 1958; 140: 381–407 BülbringE. LinR.C. The effect of intraluminal application of 5-hydroxytryptamine and 5-hydroxytryptophan on peristalsis; the local production of 5-HT and its release in relation to intraluminal pressure and propulsive activity J. Physiol. 1958 140 381 407 Search in Google Scholar

[13] Chamanara M., Rashidian A., Mehr S.E., Dehpour A.R., Shirkohi R., Akbarian R., Abdollahi A., Rezayat S.M.: Melatonin ameliorates TNBS-induced colitis in rats through the melatonin receptors: Involvement of TLR4/MyD88/NF-κB signalling pathway. Inflammopharmacology, 2019; 27: 361–371 ChamanaraM. RashidianA. MehrS.E. DehpourA.R. ShirkohiR. AkbarianR. AbdollahiA. RezayatS.M. Melatonin ameliorates TNBS-induced colitis in rats through the melatonin receptors: Involvement of TLR4/MyD88/NF-κB signalling pathway Inflammopharmacology 2019 27 361 371 10.1007/s10787-018-0523-8 Search in Google Scholar

[14] Chen C.Q., Fichna J., Bashashati M., Li Y.Y., Storr M.: Distribution, function and physiological role of melatonin in the lower gut. World J. Gastroenterol., 2011; 17: 3888–3898 ChenC.Q. FichnaJ. BashashatiM. LiY.Y. StorrM. Distribution, function and physiological role of melatonin in the lower gut World J. Gastroenterol. 2011 17 3888 3898 10.3748/wjg.v17.i34.3888 Search in Google Scholar

[15] Chen J.X., Pan H., Rothman T.P., Wade P.R., Gershon M.D.: Guinea pig 5-HT transporter: Cloning, expression, distribution, and function in intestinal sensory reception. Am. J. Physiol., 1998; 275: G433–G448 ChenJ.X. PanH. RothmanT.P. WadeP.R. GershonM.D. Guinea pig 5-HT transporter: Cloning, expression, distribution, and function in intestinal sensory reception Am. J. Physiol. 1998 275 G433 G448 10.1152/ajpgi.1998.275.3.G433 Search in Google Scholar

[16] Chojnacki C., Błasiak J., Fichna J., Chojnacki J., Popławski T.: Evaluation of melatonin secretion and metabolism exponents in patients with ulcerative and lymphocytic colitis. Molecules, 2018; 23: 272 ChojnackiC. BłasiakJ. FichnaJ. ChojnackiJ. PopławskiT. Evaluation of melatonin secretion and metabolism exponents in patients with ulcerative and lymphocytic colitis Molecules 2018 23 272 10.3390/molecules23020272 Search in Google Scholar

[17] Chojnacki C., Walecka-Kapica E., Lokieć K., Pawłowicz M., Winczyk K., Chojnacki J., Klupińska G.: Influence of melatonin on symptoms of irritable bowel syndrome in postmenopausal women. Endokrynol. Pol., 2013; 64: 114–120 ChojnackiC. Walecka-KapicaE. LokiećK. PawłowiczM. WinczykK. ChojnackiJ. KlupińskaG. Influence of melatonin on symptoms of irritable bowel syndrome in postmenopausal women Endokrynol. Pol. 2013 64 114 120 Search in Google Scholar

[18] Chojnacki C., Wisniewska-Jarosinska M., Walecka-Kapica E., Klupinska G., Jaworek J., Chojnacki J.: Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis. J. Physiol. Pharmacol., 2011; 62: 327–334 ChojnackiC. Wisniewska-JarosinskaM. Walecka-KapicaE. KlupinskaG. JaworekJ. ChojnackiJ. Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis J. Physiol. Pharmacol. 2011 62 327 334 Search in Google Scholar

[19] Coates M.D., Mahoney C.R., Linden D.R., Sampson J.E., Chen J., Blaszyk H., Crowell M.D., Sharkey K.A., Gershon M.D., Mawe G.M., Moses P.L.: Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology, 2004; 126: 1657–1664 CoatesM.D. MahoneyC.R. LindenD.R. SampsonJ.E. ChenJ. BlaszykH. CrowellM.D. SharkeyK.A. GershonM.D. MaweG.M. MosesP.L. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome Gastroenterology 2004 126 1657 1664 10.1053/j.gastro.2004.03.013 Search in Google Scholar

[20] Coates M.D., Tekin I., Vrana K.E., Mawe G.M.: Review article: The many potential roles of intestinal serotonin (5-hydroxytryptamine, 5-HT) signalling in inflammatory bowel disease. Aliment. Pharmacol. Ther., 2017; 46: 569–580 CoatesM.D. TekinI. VranaK.E. MaweG.M. Review article: The many potential roles of intestinal serotonin (5-hydroxytryptamine, 5-HT) signalling in inflammatory bowel disease Aliment. Pharmacol. Ther. 2017 46 569 580 10.1111/apt.14226 Search in Google Scholar

[21] Costedio M.M., Coates M.D., Danielson A.B., Buttolph T.R.3rd, Blaszyk H.J., Mawe G.M., Hyman N.H.: Serotonin signaling in diverticular disease. J. Gastrointest. Surg., 2008; 12: 1439–1445 CostedioM.M. CoatesM.D. DanielsonA.B. ButtolphT.R.3rd. BlaszykH.J. MaweG.M. HymanN.H. Serotonin signaling in diverticular disease J. Gastrointest. Surg. 2008 12 1439 1445 10.1007/s11605-008-0536-5 Search in Google Scholar

[22] Deiteren A., De Man J.G., Pelckmans P.A., De Winter B.Y.: Histamine H4 receptors in the gastrointestinal tract. Br. J. Pharmacol., 2015; 172: 1165–1178 DeiterenA. De ManJ.G. PelckmansP.A. De WinterB.Y. Histamine H4 receptors in the gastrointestinal tract Br. J. Pharmacol. 2015 172 1165 1178 10.1111/bph.12989 Search in Google Scholar

[23] Deiteren A., De Man J.G., Ruyssers N.E., Moreels T.G., Pelckmans P.A., De Winter B.Y.: Histamine H4 and H1 receptors contribute to postinflammatory visceral hypersensitivity. Gut, 2014; 63: 1873–1882 DeiterenA. De ManJ.G. RuyssersN.E. MoreelsT.G. PelckmansP.A. De WinterB.Y. Histamine H4 and H1 receptors contribute to postinflammatory visceral hypersensitivity Gut 2014 63 1873 1882 10.1136/gutjnl-2013-305870 Search in Google Scholar

[24] Dunlop S.P., Coleman N.S., Blackshaw E., Perkins A.C., Singh G., Marsden C.A., Spiller R.C.: Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin. Gastroenterol. Hepatol., 2005; 3: 349–357 DunlopS.P. ColemanN.S. BlackshawE. PerkinsA.C. SinghG. MarsdenC.A. SpillerR.C. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome Clin. Gastroenterol. Hepatol. 2005 3 349 357 10.1016/S1542-3565(04)00726-8 Search in Google Scholar

[25] Dunlop S.P., Jenkins D., Neal K.R., Spiller R.C.: Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology, 2003; 125: 1651–1659 DunlopS.P. JenkinsD. NealK.R. SpillerR.C. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS Gastroenterology 2003 125 1651 1659 10.1053/j.gastro.2003.09.02814724817 Search in Google Scholar

[26] Eisenhofer G., Aneman A., Friberg P., Hooper D., Fåndriks L., Lonroth H., Hunyady B., Mezey E.: Substantial production of dopamine in the human gastrointestinal tract. J. Clin. Endocrinol. Metab., 1997; 82: 3864–3871 EisenhoferG. AnemanA. FribergP. HooperD. FåndriksL. LonrothH. HunyadyB. MezeyE. Substantial production of dopamine in the human gastrointestinal tract J. Clin. Endocrinol. Metab. 1997 82 3864 3871 10.1210/jcem.82.11.43399360553 Search in Google Scholar

[27] Esteban-Zubero E., López-Pingarrón L., Alatorre-Jimenéz M.A., Ochoa-Moneo P., Buisac-Ramón C., Rivas-Jimenéz M., Castán-Ruiz S., Antoñanzas-Lombarte A., Tan D.X., García J.J., Reiter R.J.: Melatonin’s role as a co-adjuvant treatment in colonic diseases: A review. Life. Sci., 2017; 170: 72–81 Esteban-ZuberoE. López-PingarrónL. Alatorre-JimenézM.A. Ochoa-MoneoP. Buisac-RamónC. Rivas-JimenézM. Castán-RuizS. Antoñanzas-LombarteA. TanD.X. GarcíaJ.J. ReiterR.J. Melatonin’s role as a co-adjuvant treatment in colonic diseases: A review Life. Sci. 2017 170 72 81 10.1016/j.lfs.2016.11.03127919824 Search in Google Scholar

[28] Fabisiak A., Wlodarczyk J., Fabisiak N., Storr M., Fichna J.: Targeting histamine receptors in irritable bowel syndrome: A critical appraisal. J. Neurogastroenterol. Motil., 2017; 23: 341–348 FabisiakA. WlodarczykJ. FabisiakN. StorrM. FichnaJ. Targeting histamine receptors in irritable bowel syndrome: A critical appraisal J. Neurogastroenterol. Motil. 2017 23 341 348 10.5056/jnm16203550328328551943 Search in Google Scholar

[29] Fakhfouri G., Rahimian R., Daneshmand A., Bahremand A., Rasouli M.R., Dehpour A.R., Mehr S.E., Mousavizadeh K.: Granisetron ameliorates acetic acid-induced colitis in rats. Hum. Exp. Toxicol., 2010; 29: 321–328 FakhfouriG. RahimianR. DaneshmandA. BahremandA. RasouliM.R. DehpourA.R. MehrS.E. MousavizadehK. Granisetron ameliorates acetic acid-induced colitis in rats Hum. Exp. Toxicol. 2010 29 321 328 10.1177/096032711036270220154102 Search in Google Scholar

[30] Fernández-Gil B., Moneim A.E., Ortiz F., Shen Y.Q., Soto-Mercado V., Mendivil-Perez M., Guerra-Librero A., Acuña-Castroviejo D., Molina-Navarro M.M., García-Verdugo J.M., Sayed R.K., Florido J., Luna J.D., López L.C., Escames G.: Melatonin protects rats from radiotherapy-induced small intestine toxicity. PLoS One, 2017; 12: e0174474 Fernández-GilB. MoneimA.E. OrtizF. ShenY.Q. Soto-MercadoV. Mendivil-PerezM. Guerra-LibreroA. Acuña-CastroviejoD. Molina-NavarroM.M. García-VerdugoJ.M. SayedR.K. FloridoJ. LunaJ.D. LópezL.C. EscamesG. Melatonin protects rats from radiotherapy-induced small intestine toxicity PLoS One 2017 12 e0174474 10.1371/journal.pone.0174474538962428403142 Search in Google Scholar

[31] Gershon M.D., Tack J.: The serotonin signaling system: From basic understanding to drug development for functional GI disorders. Gastroenterology, 2007; 132: 397–414 GershonM.D. TackJ. The serotonin signaling system: From basic understanding to drug development for functional GI disorders Gastroenterology 2007 132 397 414 10.1053/j.gastro.2006.11.00217241888 Search in Google Scholar

[32] Ghia J.E., Li N., Wang H., Collins M., Deng Y., El-Sharkawy R.T., Côté F., Mallet J., Khan W.I.: Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology, 2009; 137: 1649–1660 GhiaJ.E. LiN. WangH. CollinsM. DengY. El-SharkawyR.T. CôtéF. MalletJ. KhanW.I. Serotonin has a key role in pathogenesis of experimental colitis Gastroenterology 2009 137 1649 1660 10.1053/j.gastro.2009.08.04119706294 Search in Google Scholar

[33] Greig C.J., Zhang L., Cowles R.A.: Potentiated serotonin signaling in serotonin re-uptake transporter knockout mice increases enterocyte mass and small intestinal absorptive function. Physiol. Rep., 2019; 7: e14278 GreigC.J. ZhangL. CowlesR.A. Potentiated serotonin signaling in serotonin re-uptake transporter knockout mice increases enterocyte mass and small intestinal absorptive function Physiol. Rep. 2019 7 e14278 10.14814/phy2.14278685460531724827 Search in Google Scholar

[34] Hoffman J.M., Tyler K., MacEachern S.J., Balemba O.B., Johnson A.C., Brooks E.M., Zhao H., Swain G.M., Moses P.L., Galligan J.J., Sharkey K.A., Greenwood-Van Meerveld B., Mawe G.M.: Activation of colonic mucosal 5-HT4 receptors accelerates propulsive motility and inhibits visceral hypersensitivity. Gastroenterology, 2012; 142: 844–854 HoffmanJ.M. TylerK. MacEachernS.J. BalembaO.B. JohnsonA.C. BrooksE.M. ZhaoH. SwainG.M. MosesP.L. GalliganJ.J. SharkeyK.A. Greenwood-Van MeerveldB. MaweG.M. Activation of colonic mucosal 5-HT4 receptors accelerates propulsive motility and inhibits visceral hypersensitivity Gastroenterology 2012 142 844 854 10.1053/j.gastro.2011.12.041347754522226658 Search in Google Scholar

[35] Irving H.R., Tan Y.Y., Tochon-Danguy N., Liu H., Chetty N., Desmond P.V., Pouton C.W., Coupar I.M.: Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon. Life. Sci., 2007; 80: 1198–1205 IrvingH.R. TanY.Y. Tochon-DanguyN. LiuH. ChettyN. DesmondP.V. PoutonC.W. CouparI.M. Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon Life. Sci. 2007 80 1198 1205 10.1016/j.lfs.2006.12.025 Search in Google Scholar

[36] Keely S.J., Stack W.A., O’Donoghue D.P., Baird A.W.: Regulation of ion transport by histamine in human colon. Eur. J. Pharmacol., 1995; 279: 203–209 KeelyS.J. StackW.A. O’DonoghueD.P. BairdA.W. Regulation of ion transport by histamine in human colon Eur. J. Pharmacol. 1995 279 203 209 10.1016/0014-2999(95)00156-F Search in Google Scholar

[37] Kendig D.M., Grider J.R.: Serotonin and colonic motility. Neurogastroenterol. Motil., 2015; 27: 899–905 KendigD.M. GriderJ.R. Serotonin and colonic motility Neurogastroenterol. Motil. 2015 27 899 905 10.1111/nmo.12617447727526095115 Search in Google Scholar

[38] Kim D., Kim W., Jeong S., Kim D., Yoo J.W., Jung Y.: Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery. Drug Deliv. Transl. Res., 2019; 9: 334–343 KimD. KimW. JeongS. KimD. YooJ.W. JungY. Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery Drug Deliv. Transl. Res. 2019 9 334 343 10.1007/s13346-018-00599-730426357 Search in Google Scholar

[39] Kim H., Dwyer L., Song J.H., Martin-Cano F.E., Bahney J., Peri L., Britton F.C., Sanders K.M., Koh S.D.: Identification of histamine receptors and effects of histamine on murine and simian colonic excitability. Neurogastroenterol. Motil., 2011; 23: 949–e409 KimH. DwyerL. SongJ.H. Martin-CanoF.E. BahneyJ. PeriL. BrittonF.C. SandersK.M. KohS.D. Identification of histamine receptors and effects of histamine on murine and simian colonic excitability Neurogastroenterol. Motil. 2011 23 949 e409 10.1111/j.1365-2982.2011.01760.x317357421806740 Search in Google Scholar

[40] Kim J.J., Bridle B.W., Ghia J.E., Wang H., Syed S.N., Manocha M.M., Rengasamy P., Shajib M.S., Wan Y., Hedlund P.B., Khan W.I.: Targeted inhibition of serotonin type 7 (5-HT7) receptor function modulates immune responses and reduces the severity of intestinal inflammation. J. Immunol., 2013; 190: 4795–4804 KimJ.J. BridleB.W. GhiaJ.E. WangH. SyedS.N. ManochaM.M. RengasamyP. ShajibM.S. WanY. HedlundP.B. KhanW.I. Targeted inhibition of serotonin type 7 (5-HT7) receptor function modulates immune responses and reduces the severity of intestinal inflammation J. Immunol. 2013 190 4795 4804 10.4049/jimmunol.120188723554310 Search in Google Scholar

[41] Kuhne S., Wijtmans M., Lim H.D., Leurs R., de Esch I.J.: Several down, a few to go: Histamine H3 receptor ligands making the final push towards the market? Expert. Opin. Investig. Drugs, 2011; 20: 1629–1648 KuhneS. WijtmansM. LimH.D. LeursR. de EschI.J. Several down, a few to go: Histamine H3 receptor ligands making the final push towards the market? Expert. Opin. Investig. Drugs 2011 20 1629 1648 10.1517/13543784.2011.62501021992603 Search in Google Scholar

[42] Lanfranchi G.A., Marzio L., Cortini C., Osset E.M.: Motor effect of dopamine on human sigmoid colon. Evidence for specific receptors. Am. J. Dig. Dis., 1978; 23: 257–263 LanfranchiG.A. MarzioL. CortiniC. OssetE.M. Motor effect of dopamine on human sigmoid colon. Evidence for specific receptors Am. J. Dig. Dis. 1978 23 257 263 10.1007/BF01072326665614 Search in Google Scholar

[43] Li N., Ghia J.E., Wang H., McClemens J., Cote F., Suehiro Y., Mallet J., Khan W.I.: Serotonin activates dendritic cell function in the context of gut inflammation. Am. J. Pathol., 2011; 178: 662–671 LiN. GhiaJ.E. WangH. McClemensJ. CoteF. SuehiroY. MalletJ. KhanW.I. Serotonin activates dendritic cell function in the context of gut inflammation Am. J. Pathol. 2011 178 662 671 10.1016/j.ajpath.2010.10.028306990721281798 Search in Google Scholar

[44] Li Y., Zhang Y., Zhang X.L., Feng X.Y., Liu C.Z., Zhang X.N., Quan Z.S., Yan J.T., Zhu J.X.: Dopamine promotes colonic mucus secretion through dopamine D5 receptor in rats. Am. J. Physiol. Cell. Physiol., 2019; 316: C393–C403 LiY. ZhangY. ZhangX.L. FengX.Y. LiuC.Z. ZhangX.N. QuanZ.S. YanJ.T. ZhuJ.X. Dopamine promotes colonic mucus secretion through dopamine D5 receptor in rats Am. J. Physiol. Cell. Physiol. 2019 316 C393 C403 10.1152/ajpcell.00261.201730624983 Search in Google Scholar

[45] Li Z., Chalazonitis A., Huang Y.Y., Mann J.J., Margolis K.G., Yang Q.M., Kim D.O., Côté F., Mallet J., Gershon M.D.: Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons. J. Neurosci., 2011; 31: 8998–9009 LiZ. ChalazonitisA. HuangY.Y. MannJ.J. MargolisK.G. YangQ.M. KimD.O. CôtéF. MalletJ. GershonM.D. Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons J. Neurosci. 2011 31 8998 9009 10.1523/JNEUROSCI.6684-10.2011444209421677183 Search in Google Scholar

[46] Li Z.S., Schmauss C., Cuenca A., Ratcliffe E., Gershon M.D.: Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: Analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice. J. Neurosci., 2006; 26: 2798–2807 LiZ.S. SchmaussC. CuencaA. RatcliffeE. GershonM.D. Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: Analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice J. Neurosci. 2006 26 2798 2807 10.1523/JNEUROSCI.4720-05.2006667516216525059 Search in Google Scholar

[47] Liu C.Z., Zhang X.L., Zhou L., Wang T., Quan Z.S., Zhang Y., Li J., Li G.W., Zheng L.F., Li L.S., Zhu J.X.: Rasagiline, an inhibitor of MAOB, decreases colonic motility through elevating colonic dopamine content. Neurogastroenterol. Motil., 2018; 30: e13390 LiuC.Z. ZhangX.L. ZhouL. WangT. QuanZ.S. ZhangY. LiJ. LiG.W. ZhengL.F. LiL.S. ZhuJ.X. Rasagiline, an inhibitor of MAOB, decreases colonic motility through elevating colonic dopamine content Neurogastroenterol. Motil 2018 30 e13390 10.1111/nmo.1339029956417 Search in Google Scholar

[48] Liu M., Geddis M.S., Wen Y., Setlik W., Gershon M.D.: Expression and function of 5-HT4 receptors in the mouse enteric nervous system. Am. J. Physiol. Gastrointest. Liver Physiol., 2005; 289: G1148–G1163 LiuM. GeddisM.S. WenY. SetlikW. GershonM.D. Expression and function of 5-HT4 receptors in the mouse enteric nervous system Am. J. Physiol. Gastrointest. Liver Physiol. 2005 289 G1148 G1163 10.1152/ajpgi.00245.200516037544 Search in Google Scholar

[49] Liu M.T., Kuan Y.H., Wang J., Hen R., Gershon M.D.: 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J. Neurosci., 2009; 29: 9683–9699 LiuM.T. KuanY.H. WangJ. HenR. GershonM.D. 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice J. Neurosci. 2009 29 9683 9699 10.1523/JNEUROSCI.1145-09.2009274987919657021 Search in Google Scholar

[50] Lu W.Z., Gwee K.A., Moochhalla S., Ho K.Y.: Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: A double-blind placebo-controlled study. Aliment. Pharmacol. Ther, 2005; 22: 927–934 LuW.Z. GweeK.A. MoochhallaS. HoK.Y. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: A double-blind placebo-controlled study Aliment. Pharmacol. Ther 2005 22 927 934 10.1111/j.1365-2036.2005.02673.x16268966 Search in Google Scholar

[51] Magro F., Vieira-Coelho M.A., Fraga S., Serrão M.P., Veloso F.T., Ribeiro T., Soares-da-Silva P.: Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease. Dig. Dis. Sci., 2002; 47: 216–224 MagroF. Vieira-CoelhoM.A. FragaS. SerrãoM.P. VelosoF.T. RibeiroT. Soares-da-SilvaP. Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease Dig. Dis. Sci. 2002 47 216 224 10.1023/A:1013256629600 Search in Google Scholar

[52] Margolis K.G., Li Z., Stevanovic K., Saurman V., Israelyan N., Anderson G.M., Snyder I., Veenstra-VanderWeele J., Blakely R.D., Gershon M.D.: Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function. J. Clin. Invest., 2016; 126: 2221–2235 MargolisK.G. LiZ. StevanovicK. SaurmanV. IsraelyanN. AndersonG.M. SnyderI. Veenstra-VanderWeeleJ. BlakelyR.D. GershonM.D. Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function J. Clin. Invest. 2016 126 2221 2235 10.1172/JCI84877488717427111230 Search in Google Scholar

[53] Margolis K.G., Stevanovic K., Li Z., Yang Q.M., Oravecz T., Zambrowicz B., Jhaver K.G., Diacou A., Gershon M.D.: Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine. Gut, 2014; 63: 928–937 MargolisK.G. StevanovicK. LiZ. YangQ.M. OraveczT. ZambrowiczB. JhaverK.G. DiacouA. GershonM.D. Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine Gut 2014 63 928 937 10.1136/gutjnl-2013-304901403468123749550 Search in Google Scholar

[54] Martin A.M., Lumsden A.L., Young R.L., Jessup C.F., Spencer N.J., Keating D.J.: Regional differences in nutrient-induced secretion of gut serotonin. Physiol. Rep., 2017; 5: e13199 MartinA.M. LumsdenA.L. YoungR.L. JessupC.F. SpencerN.J. KeatingD.J. Regional differences in nutrient-induced secretion of gut serotonin Physiol. Rep. 2017 5 e13199 10.14814/phy2.13199537156628320893 Search in Google Scholar

[55] Mawe G.M., Hoffman J.M.: Serotonin signalling in the gut – functions, dysfunctions and therapeutic targets. Nat. Rev. Gastroenterol. Hepatol. 2013; 10: 473–486 MaweG.M. HoffmanJ.M. Serotonin signalling in the gut – functions, dysfunctions and therapeutic targets Nat. Rev. Gastroenterol. Hepatol 2013 10 473 486 10.1038/nrgastro.2013.105 Search in Google Scholar

[56] Miwa J., Echizen H., Matsueda K., Umeda N.: Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits. Digestion., 2001; 63: 188–194 MiwaJ. EchizenH. MatsuedaK. UmedaN. Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits Digestion. 2001 63 188 194 10.1159/000051888 Search in Google Scholar

[57] Mousavizadeh K., Rahimian R., Fakhfouri G., Aslani F.S., Ghafourifar P.: Anti-inflammatory effects of 5-HT receptor antagonist, tropisetron on experimental colitis in rats. Eur. J Clin. Invest., 2009; 39: 375–383 MousavizadehK. RahimianR. FakhfouriG. AslaniF.S. GhafourifarP. Anti-inflammatory effects of 5-HT receptor antagonist, tropisetron on experimental colitis in rats Eur. J Clin. Invest. 2009 39 375 383 10.1111/j.1365-2362.2009.02102.x Search in Google Scholar

[58] Riley J.F., West G.B.: Histamine in tissue mast cells. J. Physiol., 1952; 117: 72P–73P RileyJ.F. WestG.B. Histamine in tissue mast cells J. Physiol. 1952 117 72P 73P 10.1126/science.118.3064.332 Search in Google Scholar

[59] Saha L., Malhotra S., Rana S., Bhasin D., Pandhi P.: A preliminary study of melatonin in irritable bowel syndrome. J. Clin. Gastroenterol., 2007; 41: 29–32 SahaL. MalhotraS. RanaS. BhasinD. PandhiP. A preliminary study of melatonin in irritable bowel syndrome J. Clin. Gastroenterol. 2007 41 29 32 10.1097/MCG.0b013e31802df84c Search in Google Scholar

[60] Salaga M., Binienda A., Piscitelli F., Mokrowiecka A., Cygankiewicz A.I., Verde R., Malecka-Panas E., Kordek R., Krajewska W.M., Di Marzo V., Fichna J.: Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system. Biochem. Pharmacol., 2019; 161: 37–51 SalagaM. BiniendaA. PiscitelliF. MokrowieckaA. CygankiewiczA.I. VerdeR. Malecka-PanasE. KordekR. KrajewskaW.M. Di MarzoV. FichnaJ. Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system Biochem. Pharmacol. 2019 161 37 51 10.1016/j.bcp.2019.01.001 Search in Google Scholar

[61] Sander L.E., Lorentz A., Sellge G., Coëffier M., Neipp M., Veres T., Frieling T., Meier P.N., Manns M.P., Bischoff S.C.: Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract. Gut, 2006; 55: 498–504 SanderL.E. LorentzA. SellgeG. CoëffierM. NeippM. VeresT. FrielingT. MeierP.N. MannsM.P. BischoffS.C. Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract Gut 2006 55 498 504 10.1136/gut.2004.061762 Search in Google Scholar

[62] Shajib M.S., Chauhan U., Adeeb S., Chetty Y., Armstrong D., Halder S.L.S., Marshall J.K., Khan W.I.: Characterization of serotonin signaling components in patients with inflammatory bowel disease. J. Can. Assoc. Gastroenterol., 2019; 2: 132–140 ShajibM.S. ChauhanU. AdeebS. ChettyY. ArmstrongD. HalderS.L.S. MarshallJ.K. KhanW.I. Characterization of serotonin signaling components in patients with inflammatory bowel disease J. Can. Assoc. Gastroenterol. 2019 2 132 140 10.1093/jcag/gwy039 Search in Google Scholar

[63] Shang B., Shi H., Wang X., Guo X., Wang N., Wang Y., Dong L.: Protective effect of melatonin on myenteric neuron damage in experimental colitis in rats. Fundam. Clin. Pharmacol., 2016; 30: 117–127 ShangB. ShiH. WangX. GuoX. WangN. WangY. DongL. Protective effect of melatonin on myenteric neuron damage in experimental colitis in rats Fundam. Clin. Pharmacol. 2016 30 117 127 10.1111/fcp.12181 Search in Google Scholar

[64] Singaram C., Ashraf W., Gaumnitz E.A., Torbey C., Sengupta A., Pfeiffer R., Quigley E.M.: Dopaminergic defect of enteric nervous system in Parkinson’s disease patients with chronic constipation. Lancet, 1995; 346: 861–864 SingaramC. AshrafW. GaumnitzE.A. TorbeyC. SenguptaA. PfeifferR. QuigleyE.M. Dopaminergic defect of enteric nervous system in Parkinson’s disease patients with chronic constipation Lancet 1995 346 861 864 10.1016/S0140-6736(95)92707-7 Search in Google Scholar

[65] Smith T.K., Dickson E.J., Heredia D.J., Hennig G.W., Bayguinov P.O.: Controversies involving the role of 5-hydroxytryptamine in generating colonic migrating motor complexes: What is spontaneous? Gastroenterology, 2010; 138: 1213–1214 SmithT.K. DicksonE.J. HerediaD.J. HennigG.W. BayguinovP.O. Controversies involving the role of 5-hydroxytryptamine in generating colonic migrating motor complexes: What is spontaneous? Gastroenterology 2010 138 1213 1214 10.1053/j.gastro.2009.11.057298277620102760 Search in Google Scholar

[66] Söderquist F., Hellström P.M., Cunningham J.L.: Human gastroenteropancreatic expression of melatonin and its receptors MT1 and MT2. PLoS One, 2015; 10: e0120195 SöderquistF. HellströmP.M. CunninghamJ.L. Human gastroenteropancreatic expression of melatonin and its receptors MT1 and MT2 PLoS One 2015 10 e0120195 10.1371/journal.pone.0120195437886025822611 Search in Google Scholar

[67] Song G.H., Leng P.H., Gwee K.A., Moochhala S.M., Ho K.Y.: Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: A randomised, double blind, placebo controlled study. Gut, 2005; 54: 1402–1407 SongG.H. LengP.H. GweeK.A. MoochhalaS.M. HoK.Y. Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: A randomised, double blind, placebo controlled study Gut 2005 54 1402 1407 10.1136/gut.2004.062034177471715914575 Search in Google Scholar

[68] Spiller R.C., Jenkins D., Thornley J.P., Hebden J.M., Wright T., Skinner M., Neal K.R.: Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut, 2000; 47: 804–811 SpillerR.C. JenkinsD. ThornleyJ.P. HebdenJ.M. WrightT. SkinnerM. NealK.R. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome Gut 2000 47 804 811 10.1136/gut.47.6.804172814711076879 Search in Google Scholar

[69] Sullivant A., Mackin A., Pharr T., Cooley J., Wills R., Archer T.: Identification of histamine receptors in the canine gastrointestinal tract. Vet. Immunol. Immunopathol., 2016; 182: 29–36 SullivantA. MackinA. PharrT. CooleyJ. WillsR. ArcherT. Identification of histamine receptors in the canine gastrointestinal tract Vet. Immunol. Immunopathol. 2016 182 29 36 10.1016/j.vetimm.2016.09.01027863547 Search in Google Scholar

[70] Thor P.J., Krolczyk G., Gil K., Zurowski D., Nowak L.: Melatonin and serotonin effects on gastrointestinal motility. J. Physiol. Pharmacol., 2007; 58: 97–103 ThorP.J. KrolczykG. GilK. ZurowskiD. NowakL. Melatonin and serotonin effects on gastrointestinal motility J. Physiol. Pharmacol. 2007 58 97 103 Search in Google Scholar

[71] Tolstanova G., Deng X., Ahluwalia A., Paunovic B., Prysiazhniuk A., Ostapchenko L., Tarnawski A., Sandor Z., Szabo S.: Role of dopamine and D2 dopamine receptor in the pathogenesis of inflammatory bowel disease. Dig. Dis. Sci., 2015; 60: 2963–2975 TolstanovaG. DengX. AhluwaliaA. PaunovicB. PrysiazhniukA. OstapchenkoL. TarnawskiA. SandorZ. SzaboS. Role of dopamine and D2 dopamine receptor in the pathogenesis of inflammatory bowel disease Dig. Dis. Sci. 2015 60 2963 2975 10.1007/s10620-015-3698-525972152 Search in Google Scholar

[72] Twarog B.M., Page I.H.: Serotonin content of some mammalian tissues and urine and a method for its determination. Am. J. Physiol., 1953; 175: 157–161 TwarogB.M. PageI.H. Serotonin content of some mammalian tissues and urine and a method for its determination Am. J. Physiol. 1953 175 157 161 10.1152/ajplegacy.1953.175.1.15713114371 Search in Google Scholar

[73] Vaughan C.J., Aherne A.M., Lane E., Power O., Carey R.M., O’Connell D.P.: Identification and regional distribution of the dopamine D1A receptor in the gastrointestinal tract. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2000; 279: R599–R609 VaughanC.J. AherneA.M. LaneE. PowerO. CareyR.M. O’ConnellD.P. Identification and regional distribution of the dopamine D1A receptor in the gastrointestinal tract Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000 279 R599 R609 10.1152/ajpregu.2000.279.2.R59910938251 Search in Google Scholar

[74] Walker J.K., Gainetdinov R.R., Mangel A.W., Caron M.G., Shetzline M.A.: Mice lacking the dopamine transporter display altered regulation of distal colonic motility. Am. J. Physiol. Gastrointest. Liver Physiol., 2000; 279: G311–G318 WalkerJ.K. GainetdinovR.R. MangelA.W. CaronM.G. ShetzlineM.A. Mice lacking the dopamine transporter display altered regulation of distal colonic motility Am. J. Physiol. Gastrointest. Liver Physiol. 2000 279 G311 G318 10.1152/ajpgi.2000.279.2.G31110915639 Search in Google Scholar

[75] Walther D.J., Peter J.U., Bashammakh S., Hörtnagl H., Voits M., Fink H., Bader M.: Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science, 2003; 299: 76 WaltherD.J. PeterJ.U. BashammakhS. HörtnaglH. VoitsM. FinkH. BaderM. Synthesis of serotonin by a second tryptophan hydroxylase isoform Science 2003 299 76 10.1126/science.107819712511643 Search in Google Scholar

[76] Wu H., Liu J., Yin Y., Zhang D., Xia P., Zhu G.: Therapeutic opportunities in colorectal cancer: Focus on melatonin antioncogenic action. Biomed. Res. Int., 2019; 2019: 9740568 WuH. LiuJ. YinY. ZhangD. XiaP. ZhuG. Therapeutic opportunities in colorectal cancer: Focus on melatonin antioncogenic action Biomed. Res. Int. 2019 2019 9740568 10.1155/2019/9740568676610931637261 Search in Google Scholar

[77] Yaakob N.S., Chinkwo K.A., Chetty N., Coupar I.M., Irving H.R.: Distribution of 5-HT3, 5-HT4, and 5-HT7 receptors along the human colon. J. Neurogastroenterol. Motil., 2015; 21: 361–369 YaakobN.S. ChinkwoK.A. ChettyN. CouparI.M. IrvingH.R. Distribution of 5-HT3, 5-HT4, and 5-HT7 receptors along the human colon J. Neurogastroenterol. Motil. 2015 21 361 369 10.5056/jnm14157449691526130632 Search in Google Scholar

[78] Yang Y., Kim W., Kim D., Jeong S., Yoo J.W., Jung Y.: A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model. Drug Des. Dev. Ther., 2018; 13: 231–242 YangY. KimW. KimD. JeongS. YooJ.W. JungY. A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model Drug Des. Dev. Ther. 2018 13 231 242 10.2147/DDDT.S185257631269330643389 Search in Google Scholar

[79] Zhang X., Guo H., Xu J., Li Y., Li L., Zhang X., Li X., Fan R., Zhang Y., Duan Z., Zhu J.: Dopamine receptor D1 mediates the inhibition of dopamine on the distal colonic motility. Transl. Res., 2012; 159: 407–414 ZhangX. GuoH. XuJ. LiY. LiL. ZhangX. LiX. FanR. ZhangY. DuanZ. ZhuJ. Dopamine receptor D1 mediates the inhibition of dopamine on the distal colonic motility Transl. Res. 2012 159 407 414 10.1016/j.trsl.2012.01.00222500514 Search in Google Scholar

[80] Zielińska M., Jarmuż A., Sałaga M., Kordek R., Laudon M., Storr M., Fichna J.: Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice. Naunyn Schmiedebergs Arch. Pharmacol., 2016; 389: 511–519 ZielińskaM. JarmużA. SałagaM. KordekR. LaudonM. StorrM. FichnaJ. Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice Naunyn Schmiedebergs Arch. Pharmacol. 2016 389 511 519 10.1007/s00210-016-1214-x482335326899972 Search in Google Scholar

[81] Zizzo M.G., Bellanca A., Amato A., Serio R.: Opposite effects of dopamine on the mechanical activity of circular and longitudinal muscle of human colon. Neurogastroenterol. Motil., 2020; 32: e13811 ZizzoM.G. BellancaA. AmatoA. SerioR. Opposite effects of dopamine on the mechanical activity of circular and longitudinal muscle of human colon Neurogastroenterol. Motil. 2020 32 e13811 10.1111/nmo.1381132012410 Search in Google Scholar